drugset / Trial / NCT02183688

Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients

NCT02183688

Phase 3 Completed 1889 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

To confirm the combination rationale for the combination of ASA + paracetamol + caffeine compared with the combination of ASA + paracetamol and the individual substances ASA, paracetamol, caffeine, and placebo administered orally to headache patients for two headache episodes

Timeline

Start
1998-09
Primary completion
2003-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule Oral
Subject Acetylsalicylic Acid Unknown Oral
Subject Caffeine Small molecule Oral

Indications